Now that we have eight positive trials involving ivermectin, with 1727 people who were brave enough to take it, why has there been so little adoption of it outside two Indian states and Peru?
And this when disease rates in many countries remain stubbornly high.
Mikia
Thank you for that.
I am researching the chronology of events after the initial Monash/Melbourne Uni report on its lab trial of ivermectin on April 3.
Almost immediately Jhonny Tavarez (also spelt Johnny Tavares) began to use ivermectin in the Dominican Republic, and Morgenstern et al have now reported on that, involving nearly 4000 patients.
On June 8 the Australian National Covid Taskforce was specifically rejecting ivermectin, a cheap, safe, registered drug, in favour of remdesivir, an expensive unregistered drug. On July 8 Gorial announced his positive ivermectin pilot trial results. On July 15 one aged care home in Victoria, Australia had its first case. There would be 18 deaths there, and many in other aged care homes. On July 20 Alam’s 98% success rate with ivermectin/doxycycline was announced. On August 21 Rajter’s ICON study result in Florida was announced. On August 23 Shouman’s positive trial result of ivermectin for reducing in-family transmission was posted to the NCT.
On 15 August the Royal Australian College of General Physicians was against it, and hasn’t changed that view, despite around 14 positive papers on ivermectin now.
Apart from Goa, Odisha and Uttar Pradesh states in India which have endorsed its use, the failure elsewhere to do so officially except in Peru is beginning to look as if it has led to large scale death, continuing today, as well as massive social and economic disruption, which use of ivermectin plus secondary drug/s may well have ameliorated. And very likely still can do, before there is achievement of widespread vaccination.
Ivermectin can be a potential molecule for prophylaxis and treatment of people infected with SARS-CoV-2, due to its anti-viral properties coupled with effective cost, availability and good tolerability and safety.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434458/
Good to see that Slovakia has approved the use of ivermectin against covid for six months.
This study using ivermectin from Itajai in Brazil with n=220,000 is very interesting:
Preprint Ivermectin Prophylaxis Used for COVID-19 Reduces COVID-19 In...
- Badges
- Science topic
- Similar topics
- Linguistics
- Composition Studies
- Publication